文献速递先天性心脏病外科心外重症与机械循环支持

婴儿体内抗猪抗体:基因工程猪心脏能否作为异种移植桥接?

Anti-Pig Antibody in Infants: Can a Genetically Engineered Pig Heart Bridge to Allotransplantation?
PubMed 文献 · Ann Thorac Surg · 2019-09-30

本研究通过流式细胞术检测儿童与成人血清对野生型及三基因敲除猪红细胞的IgM/IgG结合,评估预存抗猪抗体是否阻碍婴儿心脏异种移植。结果显示仅3%血清对三基因敲除红细胞有IgM结合,<1%弱阳性IgG;心脏术后婴儿亦极少结合,提示预存抗体可能不是婴儿心脏异种移植的障碍。

要点

  • 三基因敲除猪红细胞与婴儿血清IgM/IgG结合率极低。
  • 心脏术后婴儿对三基因敲除猪红细胞几乎无抗体结合。
  • 预存抗猪抗体可能不阻碍婴儿心脏异种移植桥接。

核心结论

  • 预存抗猪抗体可能不是婴儿心脏异种移植的障碍,即使曾接受心脏手术。
  • 在充分免疫抑制治疗下,三基因敲除猪心脏移植或可作为同种移植的桥接。

研究设计与样本

  • 流式细胞术检测血清IgM或IgG与野生型及三基因敲除猪红细胞的结合,以人O型阴性红细胞为阴性对照。
  • 第1组含84例无心脏手术史的儿科患者和64例健康成人血清。
  • 第2组含25例心脏术后婴儿血清,其中10例为左心发育不良综合征姑息术后。

主要发现

  • 第1组中,80%血清对野生型红细胞有IgM结合,91%有IgG结合。
  • 第1组仅3%血清对三基因敲除红细胞有IgM结合,1例(<1%)IgG弱阳性。
  • 第2组全部25例婴儿对野生型红细胞IgM和IgG结合均增高。
  • 第2组中1例对三基因敲除红细胞有微量IgM结合,另1例有低水平IgG结合。
  • 第1期Norwood术后婴儿均未显示对三基因敲除红细胞的IgG或IgM结合。

临床怎么用

  • 婴儿心脏异种移植前可检测预存抗猪抗体,但三基因敲除猪心脏或可安全桥接。
  • 心脏术后婴儿仍可能适合异种移植桥接,需配合充分免疫抑制治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with congenital heart disease have high heart transplant waitlist mortality, and mechanical support is suboptimal. To evaluate feasibility of cardiac grafts from a genetically engineered triple-knockout pig as a bridge to allotransplantation, preformed anti-pig antibodies were measured in pediatric and adult patients. METHODS: Flow cytometry measured serum immunoglobulin M (IgM) or IgG binding to wild-type and triple-knockout red blood cells (RBCs), with binding to human O-negative RBCs as a negative control. Group 1 comprise 84 pediatric patients and 64 healthy adults' sera with no previous cardiac surgery. Group 2 comprised 25 infant's sera postcardiac surgery, including 10 after palliation for hypoplastic left heart syndrome. RESULTS: In group 1, IgM binding to wild-type RBCs occurred in 80% of sera and IgG binding occurred in in 91% of sera. Only 3% of sera showed IgM binding to triple-knockout RBCs, and 1 (<1%) was weakly positive for IgG binding. In group 2, all 25 infants demonstrated increased IgM and IgG binding to wild-type RBCs. One patient showed minimal IgM and another showed low IgG binding to triple-knockout RBCs. No infant after stage 1 Norwood demonstrated any IgG or IgM binding. CONCLUSIONS: Preformed anti-pig antibodies may not be a barrier to heart xenotransplantation in infants, even after cardiac surgery. With adequate immunosuppressive therapy, a triple-knockout pig heart transplant might function successfully as a bridge to allotransplantation.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Li Q, Hara H, Banks CA, et al. Anti-Pig Antibody in Infants: Can a Genetically Engineered Pig Heart Bridge to Allotransplantation? Ann Thorac Surg. 2019. PMID: 31580857. doi:10.1016/j.athoracsur.2019.08.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。